Two-Chain Protein Expression with Chromosomal Chaperone Integration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for producing recombinant two-chain proteins in prokaryotic host cells face challenges in achieving efficient folding, assembly, and purification, particularly for antibodies and antibody fragments, due to the formation of inclusion bodies and the need for separate expression of chaperone proteins from plasmids, which increases time and cost.

Innovation Solution

Integrating translational units encoding chaperone proteins, such as peptidyl-prolyl isomerases and protein disulfide oxidoreductases, into the host cell chromosome using non-native promoters, allowing for efficient folding and assembly of two-chain polypeptides without the need for separate plasmid-based chaperone expression.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If chaperone proteins are expressed from plasmids to improve folding and assembly of two-chain proteins, then protein folding efficiency is improved, but device complexity and manufacturing cost increase due to separate plasmid construction and optimization

Engineering Contradiction:
Improveprotein folding efficiencyVSAvoidexpression system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent merges the chaperone protein expression system with the target protein expression system by placing both chaperone and target protein coding sequences on the same expression vector. This eliminates the need for separate plasmid construction and integration, reducing device complexity while maintaining the folding efficiency benefits of chaperone co-expression.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent creates a universal expression vector system that can simultaneously express both chaperone proteins and various target two-chain proteins. The vector is designed with multiple multiple cloning sites and regulatory elements that allow flexible insertion of different target sequences while maintaining consistent chaperone co-expression, reducing the need for vector re-engineering for different products.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Manufacturing precision

If chaperone proteins are expressed from plasmids to improve folding and assembly, then protein assembly quality is improved, but time and cost for plasmid construction and optimization increase

Engineering Contradiction:
Improveprotein assembly qualityVSAvoidplasmid construction time
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The patent incorporates chaperone protein coding sequences pre-configured on the expression vector before target protein insertion. This preliminary arrangement of the chaperone expression framework eliminates the need for time-consuming plasmid construction and optimization steps for each new target protein, as the chaperone co-expression system is already in place and functional.

Inventive Principle:
Principle #10Preliminary action

3Productivity

If plasmid-based chaperone expression is used to increase antibody titer, then productivity is improved, but additional purification steps are required to remove chaperone proteins

Engineering Contradiction:
Improveantibody titerVSAvoidpurification process complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent applies different tagging strategies to different protein components within the same expression system. The target protein can be tagged with specific affinity tags while the chaperone protein is either left untagged or tagged differently, enabling selective purification of the target protein through affinity chromatography without requiring additional steps to remove chaperone contaminants.

Inventive Principle:
Principle #3Local quality

4Adaptability or versatility

If separate plasmids are used for chaperone and target protein expression, then expression levels can be independently optimized, but ease of manufacture decreases due to multiple vector components

Engineering Contradiction:
Improveexpression level optimizationVSAvoidvector construction ease
Core Design Contradiction:
Adaptability or versatilityVSEase of manufacture

Solution Approach 1:

The patent incorporates multiple regulatable promoters within the single vector system, allowing independent control of chaperone and target protein expression levels. The vector may contain inducible promoters with different induction conditions (e.g., different inducers or inducible at different times), enabling dynamic optimization of expression levels for both proteins without requiring separate plasmids or complex vector construction.

Inventive Principle:
Principle #15Dynamics

Data Source

PatentUS20260062710A1Methods of producing two chain proteins in prokaryotic host cells
Publication Date: 2026.03.05 GENENTECH INC
  • US20260062710A1 patent drawing
  • US20260062710A1 patent drawing
  • US20260062710A1 patent drawing

AI summary

Provided herein are methods and host cells for producing a polypeptide containing two chains, such as an antibody, half-antibody, antibody fragment, or one-armed antibody. The methods and host cells allow for two-chain polypeptide production using expression of polynucleotides encoding the polypeptide chains from extra-chromosomal polynucleotide(s), and expression of one or more chaperone protein(s) (e.g., peptidyl-prolyl isomerases and/or protein disulfide oxidoreductases) from the host cell chromosome using non-native combination(s) of promoters and translational units encoding a chaperone protein.